Literature DB >> 29770917

Readmission After Abdominal Surgery for Crohn's Disease: Identification of High-Risk Patients.

Diane Mege1, Fabrizio Michelassi2.   

Abstract

BACKGROUND: Although many predictive factors for postoperative morbidity are known, few data are available about readmission after abdominal surgery for Crohn's disease (CD). The objective of this study is to identify predictive factors and high-risk patients for readmission after abdominal CD surgery.
METHODS: All patients who underwent abdominal surgery for CD in one tertiary referral center between January 2004 and December 2016 were included. Patients who required readmission and those without were compared. Perineal procedures, elective readmissions, and abdominal procedures for non-Crohn's indications were not included.
RESULTS: Nine hundred eight abdominal procedures were performed in 712 patients. Readmission rates were 8, 8.5, 8.6, 8.8, and 8.9% at 30, 60, and 90 days and 12 and 60 months, respectively. The main reasons were wound infection (14%), deep abscess (13%), small-bowel obstruction (13%), and dehydration (11%). Eight (11%) patients required percutaneous drainage and 19 (27%) underwent an unplanned surgery. After multivariate analysis, three independent predictive factors for readmission were identified: older age (OR 1.02, 95%CI 1.005-1.04; p < 0.006), a history of previous proctectomy (OR 3, 95%CI 1.2-9, p < 0.02), and higher blood loss volume during surgery (OR 1.0001, 95%CI 1-1.002, p < 0.05).
CONCLUSION: Readmission occurred in 8-9% of abdominal procedures for CD within 1-3 months after surgery and it required unplanned reoperation in a quarter of them. Identification of high-risk groups and knowledge of the more common postoperative complications requiring readmission help in increasing postoperative vigilance to select patients who may benefit from early interventions.

Entities:  

Keywords:  Crohn’s disease; Laparoscopy; Morbidity; Readmission; Recurrence

Mesh:

Substances:

Year:  2018        PMID: 29770917     DOI: 10.1007/s11605-018-3805-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  14 in total

1.  Factors associated with readmissions and outcomes of patients hospitalized for inflammatory bowel disease.

Authors:  Geoffrey C Nguyen; Natasha Bollegala; Christopher A Chong
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-26       Impact factor: 11.382

2.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

Review 3.  Surgery for adult Crohn's disease: what is the actual risk?

Authors:  Guillaume Bouguen; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2011-05-24       Impact factor: 23.059

4.  Postoperative complications and emergent readmission in children and adults with inflammatory bowel disease who undergo intestinal resection: a population-based study.

Authors:  Alexandra Frolkis; Gilaad G Kaplan; Alka B Patel; Peter Faris; Hude Quan; Nathalie Jette; Jennifer deBruyn
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

5.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.

Authors:  Matthew J Grainge; Joe West; Timothy R Card
Journal:  Lancet       Date:  2010-02-08       Impact factor: 79.321

6.  Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?

Authors:  Evan C White; Gil Y Melmed; Eric Vasiliauskas; Marla Dubinsky; Andrew Ippoliti; Dermot McGovern; Stephan Targan; Phillip Fleshner
Journal:  Dis Colon Rectum       Date:  2012-05       Impact factor: 4.585

7.  Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.

Authors:  Kweku A Appau; Victor W Fazio; Bo Shen; James M Church; Bret Lashner; Feza Remzi; Aaron Brzezinski; Scott A Strong; Jeffrey Hammel; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

8.  Outcomes of early ileocolectomy after percutaneous drainage for perforated ileocolic Crohn's disease.

Authors:  William Sangster; Arthur S Berg; Christine S Choi; Tara M Connelly; Charles H Chesnut; Walter A Koltun; David B Stewart
Journal:  Am J Surg       Date:  2016-05-12       Impact factor: 2.565

9.  What are the consequences of enlarging the extraction site to exteriorize a large specimen during laparoscopic surgery for Crohn's enteritis?

Authors:  L C Duraes; L Stocchi; M Rottoli; M M Costedio; E Gorgun; H Kessler
Journal:  Colorectal Dis       Date:  2016-03       Impact factor: 3.788

10.  Role of exclusive enteral nutrition in the preoperative optimization of patients with Crohn's disease following immunosuppressive therapy.

Authors:  Yi Li; Lugen Zuo; Weiming Zhu; Jianfeng Gong; Wei Zhang; Lili Gu; Zhen Guo; Lei Cao; Ning Li; Jieshou Li
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.